Inherited and acquired thrombophilia in children and young adults with Bcr-Abl negative chronic myeloproliferative disorders.

被引：0
|
作者：
Giona, F [1 ]
Palumbo, G [1 ]
Pignoloni, P [1 ]
Amendola, A [1 ]
Chistolini, A [1 ]
Testi, AM [1 ]
Moleti, ML [1 ]
Foa, R [1 ]
Mazzucconi, MG [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Div Haematol, Rome, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4949
引用
收藏
页码：317B / 318B
页数：2
相关论文
共 50 条
  • [1] BCR-ABL transcripts in Philadelphia-negative myeloproliferative disorders.
    Aviram, A
    Blickstein, D
    Luboshitz, J
    Stark, P
    Bairey, O
    Prokocimer, M
    Magen, H
    Shaklai, M
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 797 - 797
  • [2] Testing in-vitro for imatinib sensitivity in BCR-ABL negative myeloproliferative disorders.
    Chase, A
    Higley, K
    Baxter, J
    Grand, F
    Grand, E
    Cross, NCP
    BLOOD, 2003, 102 (11) : 658A - 658A
  • [3] Inconsistency in the methylation status of ABL promoter in Ph-negative BCR-ABL positive and negative myeloproliferative disorders.
    Blickstein, D
    Aviram, A
    Witenberg, B
    Shaklai, M
    BLOOD, 2000, 96 (11) : 266B - 266B
  • [4] Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders
    Reiter, Andreas
    Walz, Christoph
    Cross, Nicholas C. P.
    CURRENT DRUG TARGETS, 2007, 8 (02) : 205 - 216
  • [5] BCR-ABL negative myeloproliferative neoplasms
    Metzgeroth, G.
    Lengfelder, E.
    Griesshammer, M.
    Reiter, A.
    ONKOLOGE, 2012, 18 (12): : 1130 - +
  • [6] Recent advances in the bcr-abl negative chronic myeloproliferative diseases
    Michael Bennett
    David F Stroncek
    Journal of Translational Medicine, 4
  • [7] Recent advances in the bcr-abl negative chronic myeloproliferative diseases
    Bennett, Michael
    Stroncek, David F.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2006, 4 (1)
  • [8] Bcr-abl transcript identifiable at low levels in blood in all myeloproliferative disorders.
    Singer, IO
    Sproul, A
    Tait, RC
    Soutar, R
    Gibson, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 94 - 94
  • [9] Outcome of secondary AML following BCR-ABL negative myeloproliferative disorders
    Ayari, S.
    Chevallier, P.
    Guillaume, T.
    Garant, R.
    Dubruille, V.
    Gastinne, T.
    Le Gouill, S.
    Blin, N.
    Mahe, B.
    Harousseau, J. L.
    Mohty, M.
    Moreau, P.
    Delaunay, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S90 - S91
  • [10] Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
    Mesa, Ruben A.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (02): : 129 - 138
12345